Atherosclerosis, the underlying inflammatory disease, develops through the progressive accumulation of lipids and leukocytes in the vessel wall. Over the past 30 years, lesional macrophages have emerged as central inflammatory orchestrators of disease progression and its complications. Macrophage precursors, the circulating monocytes, invade predilection sites of dysfunctional endothelium, differentiate, and engulf lipids. Lesional macrophages secrete cytokines, chemokines, growth factors, and lytic enzymes that promote plaque destabilization and rupture, which lead to myocardial infarction and stroke. Interference with monocyte recruitment and macrophage accumulation reduces lesion burden in experimental models, which suggests that such approaches could be beneficial in human disease. [2] [3] [4] Much of current cardiovascular disease management focuses on treatment of known risk factors such as high cholesterol. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, the class of drugs known as statins, lower cholesterol but also can exert atheroprotection by targeting inflammation. 5 Despite some uncertainties, the phenotype described in this work is compelling and warrants further work. It remains to be determined whether FRb-expressing macrophages represent a distinct subset of lesional macrophages or an activation state, as well as whether these macrophages are functionally distinct from their FRb-negative counterparts. As the authors mention, induction of macrophage apoptosis in atherosclerotic lesions could be a double-edged sword. Although beneficial in early stages of lesion formation, the increased cell death at more advanced stages might be detrimental. 20 It is also worth considering that folic acid and folate, also known as vitamin B9, are important to many biological functions, such as DNA synthesis and repair. Elimination of cells expressing a particular receptor could have other unforeseen effects that counterbalance the potential benefits observed in this study. Nevertheless, the authors have engineered a clever method to target a formidable cell (Figure 1) . The Greek metaphor, though imperfect, can be illustrative: If the macrophage is Achilles and the folate receptor is his Heel, then the antibody is Paris' arrow and the exotoxin the poison that ultimately kills the greatest warrior of the Trojan War.
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